Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Homelessness and high-dosage buprenorphine misuse.

T Blanchon1, A Boissonnas, I Vareseon

  • 1Départment de Santé Publique, CHU Cochin-Port Royal, Assistance Publique Hôpitaux de Paris, Université René Descartes, Paris, France.

Substance Use & Misuse
|May 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prevention of pertussis in newborns: Should pregnant women be vaccinated at each pregnancy?]

La Revue de medecine interne·2023
Same author

[Suicide prevention: How to act?]

La Revue de medecine interne·2022
Same author

Initial risk perception and feeling of preparedness of primary care physicians regarding the COVID-19 pandemic in Belgium, France and Spain in February 2020.

BMC primary care·2022
Same author

Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure.

Scientific reports·2021
Same author

[HIV prevention with PrEP: Challenges and prospects].

La Revue de medecine interne·2020
Same author

Management of work-related common mental disorders in general practice: a cross-sectional study.

BMC family practice·2020

Homeless individuals who use intravenous drugs are more likely to misuse high dosage buprenorphine (HDB). This suggests HDB maintenance therapy may not be suitable for this vulnerable population.

Area of Science:

  • Addiction medicine
  • Public health
  • Sociomedical sciences

Background:

  • High dosage buprenorphine (HDB) is used in treating opioid dependence.
  • Homelessness is a significant social determinant of health, potentially impacting treatment outcomes.
  • Understanding the specific risks associated with HDB misuse in homeless populations is crucial for harm reduction.

Purpose of the Study:

  • To investigate the association between homelessness and the misuse of high dosage buprenorphine (HDB) among intravenous drug users (IDUs).
  • To identify if homeless IDUs exhibit different patterns of HDB misuse compared to non-homeless IDUs.

Main Methods:

  • Cross-sectional study conducted between 1998 and 1999.
  • Data collected via structured questionnaires from 779 intravenous drug users (IDUs).

Related Experiment Videos

  • Participants recruited from diverse settings including treatment centers, healthcare networks, and support services.

    • Main Results:

    • Homeless IDUs were significantly more likely to inject HDB (67% vs. 47%) and engage in unsafe injection practices.
    • The initial HDB injection led to medical complications more frequently in homeless individuals (58% vs. 38%).
    • Homeless IDUs reported less medical follow-up and poorer understanding of correct HDB usage.

    Conclusions:

    • Homelessness is a significant risk factor for high dosage buprenorphine (HDB) misuse among intravenous drug users (IDUs).
    • Current HDB maintenance therapy may not be the most appropriate treatment strategy for homeless IDUs due to higher misuse rates and associated risks.
    • Targeted interventions and alternative therapeutic approaches are warranted for homeless populations undergoing opioid dependence treatment.